Senti Biosciences Holdings (SNTI) Change in Account Payables (2021 - 2025)

Senti Biosciences Holdings' Change in Account Payables history runs 5 years deep, the most recent figure standing at $1.2 million for Q4 2025.

• In Q4 2025, Change in Account Payables fell 5.33% year-over-year to $1.2 million; the TTM figure through Dec 2025 stood at $1.7 million (up 118.7% YoY), while the FY2025 annual figure was $1.7 million, up 118.7% from the prior year.
• Change in Account Payables for Q4 2025 stood at $1.2 million, up from $750000.0 in the prior quarter.
• The five-year high for Change in Account Payables was $1.2 million in Q4 2024, with the low at -$2.3 million in Q4 2021.
• The 5-year median for Change in Account Payables is $2299.0 (2021), against an average of $5381.3.
• Peak annual rise in Change in Account Payables reached 8718.97% in 2022, while the deepest fall reached 585814.29% in 2022.
• Senti Biosciences Holdings' Change in Account Payables stood at -$2.3 million in 2021, then jumped by 103.99% to $93000.0 in 2022, then sank by 911.83% to -$755000.0 in 2023, then surged by 264.11% to $1.2 million in 2024, then fell by 5.33% to $1.2 million in 2025.
• Business Quant data shows SNTI's Change in Account Payables at $1.2 million in Q4 2025, $750000.0 in Q3 2025, and -$537000.0 in Q2 2025.